CD69-triggered ERK activation and functions are negatively regulated by CD94/NKG2-A inhibitory receptor

European Journal of Immunology

Volumn 30, Issue 2, 2000, Pages 644-651

  Zingoni, Alessandra ^a   Palmieri, Gabriella ^a,b,e   Morrone, Stefania ^a   Carretero, Marta ^c   Lopez Botel, Miguel ^c   Piccoli, Mario ^a   Frati, Luigi ^a,d   Santoni, Angela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d IRCCS NEUROMED   (Italy)

^e Dept of Exp Medicine and Pathology ^*  (Italy)

Author keywords

CD69; Inhibitory receptor; NK cell; Signal transduction

Indexed keywords

CD69 ANTIGEN; CD94 ANTIGEN; HLA E ANTIGEN; LECTIN; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTOTOXICITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD94; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL LINE; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR CROSS-TALK; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0033970117     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200002)30:2<644::AID-IMMU644>3.0.CO;2-H     Document Type: Article

References (41)

1. Brown, M. G., Scalzo, A. A., Matsumoto, K. and Yokoyama, W. M., The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol. Rev. 1997. 155: 53-65.
2. Hamann, J., Fiebig, H. and Strauss, M., Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain. J. Immunol. 1993. 150: 4920-4927.
3. Lopez-Cabrera, M., Santis, A. G., Fernandez-Ruiz, E., Blacher, R., Esch, F., Sanchez-Mateos, P. and Sanchez-Madrid, F., Molecular cloning, expression and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 1993. 178: 537-547.
4. Ziegler, S. E., Ramsdell, P., Hjerrild, K. A., Armitage, R. J., Grabstein, K. H., Hennen, K. B., Farrah, T., Fanslow, W. C., Shevach, E. M. and Alderson, M. R., Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur. J. Immunol. 1993. 23: 1643-1648.
5. Testi, R., Pulcinelli, F., Frati, L., Gazzaniga, P. P. and Santoni, A., CD69 is expressed on platelets and mediates platelet activation and aggregation. J. Exp. Med. 1990. 172: 701-707.
6. De Maria, R., Cifone, M. G., Trotta, R., Rippo, M. R., Festuccia, C., Santoni, A. and Testi, R., Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J. Exp. Med. 1994. 180: 1999-2004.
7. Testi, R., D'Ambrosio, D., De Maria, R. and Santoni, A., The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 1994. 15: 479-483.
8. bright human thymocytes. J. Immunol. 1988. 141: 2557-2563.
9. Lanier, L. L., Buck, D. W., Rodhes, L., Ding, A., Evans, E., Barney, C. and Phillips, J. H., Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J. Exp. Med. 1988. 167: 1572-1585.
10. Moretta, A., Poggi, A., Pende, D., Tripodi, G., Orengo, A. M., Pella, N., Augugliaro, R., Bottino, C., Ciccone, E. and Moretta, L, CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α/β. J. Exp. Med. 1991. 174: 1393-1398.
11. Cebrian, M., Yague, E., Rincon, M., Lopez-Botet, M., de Landazuri, M. O. an Sanchez-Madrid, F., Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 1988. 168: 1621-1637.
12. Testi, R., Phillips, J. H. and Lanier, L. L., T cell activation via Leu-23 (CD69). J. Immunol. 1989. 143: 1123-1128.
13. D'Ambrosio, D., Trotta, R., Vacca, A., Frati, L., Santoni, A., Gulino, A. and Testi, R., Transcriptional regulation of interleukin-2 gene expression by CD69-generated signals. Eur. J. Immunol. 1993. 23: 2993-2998.
14. Santis, A. G., Campanero, M. R., Alonso, J. L., Tugores, A., Alonso, M. A., Yague, E., Pivel, J. P. and Sanchez-Madrid, F., Tumor necrosis factor-α production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur. J. Immunol. 1992. 22: 1253-1259.
15. 2-dependent pathway in CD69-mediated platelet activation. J. Immunol. 1992. 148: 2867-2871.
16. Seger, R. and Krebs, E. G., The MARK signaling cascade. FASEB J. 1995. 9: 726-735.
17. 2 in CD16-triggered granule exocytosis. J. Immunol. 1997. 158: 3148-3154.
18. Wei, S., Gamero, A. M., Liu, J. H., Daulton, A. A., Valkov, N. I., Trapani, J. A., Larner, A. C., Weber, M. J. and Djeu, J. Y., Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perforin and granzyme B mobilization by functional ERK2. J. Exp. Med. 1998. 187: 1753-1765.
19. Trotta, R., Puorro, K. A., Paroli, M., Azzoni, L., Abebe, B., Eisenlohr, L. C. and Perussia, B., Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases. J. Immunol. 1998. 161: 6648-6656.
20. Palmieri, G., Tullio, V., Zingoni, A., Piccoli, M., Frati, L., Lopez-Botet, M. and Santoni, A., CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. J. Immunol. 1999. 162: 7181-7188.
21. Lanier, L. L., NK cell receptors. Annu. Rev. Immunol. 1998. 16: 359-393.
22. Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C. and Moretta, L., Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 1997. 155: 105-117.
23. Long, E. O., Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 1999. 17: 875-904.
24. Lopez-Botet, M., Carretero, M., Bellon, T., Perez-Villar, J. J., Llano, M. and Navarro, F., The CD94/NKG2-A C-type lectin receptor complex. Curr. Top. Microbiol. and Immunol. 1998. 230: 41-52.
25. Lopez-Botet, M. and Bellon, T., Natural killer cell activation and inhibition by receptors for MHC class I. Curr. Op. Immunol. 1999. 11: 301-307.
26. Vivier, E. and Daeron, M., Immunoreceptor tyrosine-based inhibitor motifs. Immunol. Today 1997. 18: 286-291.
27. Carretero, M., Palmieri, G., Llano, M., Tullio, V., Santoni, A., Geraghty, D. E. and Lopez-Botet, M., Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Eur. J. Immunol. 1998. 28: 1280-1291.
28. Le Drean, E., Vely, F., Olcese, L., Cambiaggi, A., Guia, S., Krystal, G., Gervois, N., Moretta, A., Jotereau, F. and Vivier, E., Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 1998. 28: 264-276.
29. Brumbaugh, K. M., Binstadt, B. A. and Leibson, P. J., Signal transduction during NK cell activation: balancing opposite forces. Curr. Top. Microbiol. and Immunol. 1998. 230: 103-122.
30. Santini, F. and Beaven, M. A., Tyrosine phosphorylation of a Mitogen Activated Protein (MAP) kinase-like protein occurs at a late step in exocytosis: studies with tyrosine phosphatase inhibitors and various secretagogues in RBL-2H3. J Biol. Chem. 1993. 268: 22716-22722.
31. Offermanns, S., Jones, S. V. P., Bombien, E. and Schultz, G., Stimulation of mitogen-activated protein kinase activity by different secretory stimuli in rat basophilic leukemia cells. J. Immunol. 1994. 152: 250-261.
32. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. and Saltiel, A. R., PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinases in vitro and in vivo. J. Biol. Chem. 1995. 270: 27489-27494.
33. Sivori, S., Vitale, M., Bottino, C., Marcenaro, E., Sanseverino, L., Parolini, S., Moretta, L. and Moretta, A., CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 1996. 26: 2487-2492.
34. Blery, M., Delon, J., Trautmann, A., Cambiaggi, A., Olcese, L., Biassoni, R., Moretta, L., Chavrier, P., Moretta, A., Daeron, M. and Vivier, E., Reconstituted killer-cell inhibitory receptors for MHC class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs. J. Biol. Chem. 1997. 272: 8989-8996.
35. Tugores, A., Alonso, M. A., Sanchez-Madrid, F. and de Landazuri, M. O., Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1. J. Immunol. 1992. 148: 2300-2306.
36. 2 is phosphorylated and activated by MAP kinase. Cell 1993. 72: 269-278.
37. Cifone, M. G., Roncaioli, P., Cironi, L., Festuccia, C., Meccia, A., D'Alo', S., Botti, D. and Santoni, A., NKR-P1A stimulation of arachidonate-generating enzymes in rat NK cells is associated with granule release and cytotoxic activity. J. Immunol. 1997. 159: 309-317.
38. Risso, A., Smilovich, D., Capra, M. C., Baldissarro, I., Yan, G., Bargellesi, A. and Cosulich, M. E., CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. J. Immunol. 1991. 146: 4105-4114.
39. Lanier, L. L., Corliss, B. and Phillips, J. H., Arousal and inhibition of human NK cells. Immunol. Rev. 1997. 155: 145-154.
40. Borrego, F., Robertson, M. J., Ritz, J., Pena, J. and Solana, R., CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology 1999. 97: 159-165.
41. + T lymphocytes: inhibition of IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. J. Immunol. 1990. 144: 3238-3247.